These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19747967)

  • 21. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect.
    Sugano K
    Int J Pharm; 2010 Mar; 387(1-2):103-9. PubMed ID: 20006692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dry coating, a novel coating technology for solid pharmaceutical dosage forms.
    Luo Y; Zhu J; Ma Y; Zhang H
    Int J Pharm; 2008 Jun; 358(1-2):16-22. PubMed ID: 18467045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An integrated Quality by Design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation.
    Adam S; Suzzi D; Radeke C; Khinast JG
    Eur J Pharm Sci; 2011 Jan; 42(1-2):106-15. PubMed ID: 21056102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What can we learn from atomic force microscopy adhesion measurements with single drug particles?
    Roberts CJ
    Eur J Pharm Sci; 2005 Feb; 24(2-3):153-7. PubMed ID: 15661486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling weight variability in a pan coating process using Monte Carlo simulations.
    Pandey P; Katakdaunde M; Turton R
    AAPS PharmSciTech; 2006 Oct; 7(4):83. PubMed ID: 17233536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Uniformity of unit-dose pharmaceutical preparations. Tests for the specifications of the uniformity of the pharmacopoeias, evaluation of the permitted variability, transfer of specifications to the control of production, variability found in the Italian pharmaceutical production, proposals for future specifications of uniformity].
    Cavatorta L; Cingolani E; Fontani F; Mecarelli E; Melandri MM; Pietra E; Pietra V; Rocchi B
    Boll Chim Farm; 1973 Apr; 112(4):226-45. PubMed ID: 4721646
    [No Abstract]   [Full Text] [Related]  

  • 29. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical freezing rate in freeze drying nanocrystal dispersions.
    Lee J; Cheng Y
    J Control Release; 2006 Mar; 111(1-2):185-92. PubMed ID: 16430987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microwave-assisted extraction of active pharmaceutical ingredient from solid dosage forms.
    Hoang TH; Sharma R; Susanto D; Di Maso M; Kwong E
    J Chromatogr A; 2007 Jul; 1156(1-2):149-53. PubMed ID: 17350639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of particle sizes with metal replication under standard freeze-etching conditions: a gold ball standard for calibrating shadow widths was used to measure freeze-etched globular proteins.
    Ruben GC
    Microsc Res Tech; 1995 Nov; 32(4):312-29. PubMed ID: 8573781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane.
    Taylor PW; Keenan MH
    Curr Med Res Opin; 2006 Mar; 22(3):603-15. PubMed ID: 16574043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
    Pauli-Bruns A; Knop K; Lippold BC
    Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications.
    Jaspart S; Piel G; Delattre L; Evrard B
    Expert Opin Drug Deliv; 2005 Jan; 2(1):75-87. PubMed ID: 16296736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Rational Analysis of Uniformity Risk for Agglomerated Drug Substance Using NIR Chemical Imaging.
    Scherholz ML; Wan B; McGeorge G
    AAPS PharmSciTech; 2017 Feb; 18(2):432-440. PubMed ID: 27052406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmaceutical advice concerning different pharmaceutical dosage forms].
    Szakonyi G; Zelkó R
    Acta Pharm Hung; 2010; 80(3):121-7. PubMed ID: 21222322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrete element method (DEM) simulations of stratified sampling during solid dosage form manufacturing.
    Hancock BC; Ketterhagen WR
    Int J Pharm; 2011 Oct; 418(2):265-72. PubMed ID: 21635943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Particle Size Limits to Pass the Acceptance Value (AV)-Based USP Content Uniformity Test for Tablets.
    Lou H; Hageman MJ
    J Pharm Sci; 2021 Oct; 110(10):3527-3534. PubMed ID: 34302841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDA comments: ICH Q6A; draft guidance on specifications. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1998; 52(5):232-3. PubMed ID: 9846071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.